SMG
IMMU

Spectrum Management Group’s Immunomedics Inc IMMU Stock Holding History

Spectrum Management Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,250
Closed -$26K – 247
2018
Q3 		$26K Hold
1,250
– – 0.01% 154
2018
Q2 		$30K Sell
1,250
-1,250
-50% -$25.1K 0.01% 150
2018
Q1 		$37K Hold
2,500
– – 0.01% 138
2017
Q4 		$40K Hold
2,500
– – 0.01% 137
2017
Q3 		$35K Buy
+2,500
New +$24.9K 0.01% 192

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Spectrum Management Group's IMMU Position: Q4 2018 in Review

Spectrum Management Group sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 1,250 shares — an estimated $26K sold.

Spectrum Management Group first reported a position in IMMU in Q3 2017 and held it in 5 quarters. The position peaked at $40K in Q4 2017. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • Spectrum Management Group reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
  • Spectrum Management Group sold 1,250 Immunomedics Inc shares in Q4 2018, an estimated $26K.
  • Spectrum Management Group first reported a position in Immunomedics Inc in Q3 2017 and held it in 5 quarters.
  • Spectrum Management Group's Immunomedics Inc position peaked at $40K in Q4 2017.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on Spectrum Management Group's 13F filing for Q4 2018, filed 7 Feb 2019.